Learn More About This Eyelash Growth Treatment at Our Toronto Area Practice in North YorkDiscover the first and only FDA-approved eyelash growth treatment for amazing longer, fuller, and darker eyelashes in Latisse® at our Toronto area practice. Latisse® (bimatoprost ophthalmic solution 0.03%) is the first and only prescription treatment approved by the FDA for thin or short eyelashes to grow them longer, fuller, and darker.
Latisse® makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is not known, research suggests that the growth of eyelashes occurs by increasing the percent of hairs in, and the duration of, the anagen or growth phase. Lashes grow longer, thicker, and darker because bimatoprost can also prolong this growth phase.
Latisse® is an easy to use, once-a-day treatment you apply topically to the base of your upper eyelashes. Patients in a clinical trial saw results gradually over time (starting at four weeks, with full results after 16 weeks). It’s an innovation backed by research.